Perrigo Co PLC (PRGO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
John T. Hendrickson
Employees:
10,220
TREASURY BUILDING, LOWER GRAND CANAL STREET, DUBLIN, IRELAND L2 2
269-673-8451

Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals, and Specialty Sciences. The CHC segment includes the company's former segments, which are the Nutritionals and Israel Pharmaceuticals and Diagnostics business. The BCH segment consists of the Omega business. The Prescription Pharmaceuticals includes the Rx Pharmaceuticals business. The Specialty Sciences segment comprises of the assets, which focuses on the treatment of multiple sclerosis. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Data derived from most recent annual or quarterly report
Market Cap 6.1 Billion Shares Outstanding133.715 Million Avg 30-day Volume 1.689 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 50.9 / 37.57 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from PRGO instead.

View recent insider trading info

Funds Holding PRGO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PRGO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DOYLE KATHERINE C.

  • Director
2,931 2021-08-12 2

CLASSON ROLF A

  • Director
22,891 2021-05-17 3

KINDLER JEFFREY B

  • Director
17,574 2021-05-17 2

ASHFORD ORLANDO D

  • Director
6,599 2021-05-17 3

ALFORD BRADLEY A

  • Director
17,577 2021-05-17 2

PARKER GEOFFREY M.

  • Director
26,208 2021-05-17 3

KARABOUTIS ADRIANA

  • Director
17,046 2021-05-17 2

O'CONNOR DONAL

  • Director
21,252 2021-05-17 2

SAMUELS THEODORE R. II

  • Director
44,811 2021-05-17 3

MANN ERICA L

  • Director
12,289 2021-05-17 2

SILCOCK RAYMOND EVP, CHIEF FINANCIAL OFFICER

  • Officer
14,159 2021-04-05 2

JANISH RONALD CRAIG EVP, GBL OPS & SC & CTO

  • Officer
16,304 2021-03-10 2

KESSLER MURRAY S CEO

  • Officer
  • Director
111,499 2021-03-05 2

KINGMA TODD W EXECUTIVE VP, GENERAL COUNSEL

  • Officer
103,890 2021-03-05 1

KOCHAN SHARON EVP & PRESIDENT RX

  • Officer
81,480 2021-03-05 1

FARRINGTON THOMAS EVP AND CIO

  • Officer
39,253 2021-03-05 1

SOROTA RICHARD S EVP & PRESIDENT CSCA

  • Officer
22,126 2021-03-05 2

DILLARD JAMES E III EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
18,644 2021-03-05 2

QUINN GRAINNE EVP, CHIEF MEDICAL OFFICER

  • Officer
17,160 2021-03-05 1

ANDERSEN SVEND EVP & PRESIDENT CHCI

  • Officer
43,148 2021-03-05 1

WILLIS ROBERT EVP & CHRO

  • Officer
17,897 2021-03-05 1

NEEDHAM JEFFREY EVP, PRESIDENT CHC AMERICAS

  • Officer
31,191 2020-06-29 0

WINOWIECKI RONALD CFO

  • Officer
6,952 2019-08-22 0

SMITH JEFFREY C

  • Director
10,046,234 2019-05-15 0

WENINGER PAUL EVP, QUALITY OPERATIONS

  • Officer
5,392 2019-02-26 0

WESOLOWSKI JOHN EVP, PRESIDENT RX

  • Officer
2,431 2019-02-26 0

COHEN GARY M

  • Director
20,317 2018-11-14 0

MICHAUD JAMES R EVP, CHIEF HR OFFICER

  • Officer
0 2018-10-08 0

BRLAS LAURIE

  • Director
15,329 2018-06-06 0

ROEHRHOFF UWE CEO

  • Officer
  • Director
7,500 2018-03-08 0

HENDRICKSON JOHN T CEO

  • Officer
18,321 2017-11-03 0

JANDERNOA MICHAEL J

  • Director
No longer subject to file 2016-12-31 0

BROWN JUDY L EVP, BUSINESS OPS & CFO

  • Officer
10,007 2016-11-25 0

KUNKLE GARY K JR

  • Director
25,687 2016-09-09 0

MORRIS HERMAN JR

  • Director
10,202 2016-09-08 0

HOFFING ELLEN RANDI

  • Director
9,084 2016-05-19 0

YANAI SHLOMO

  • Director
443 2016-05-19 0

FOUSE JACQUALYN A

  • Director
3,916 2016-05-04 0

PAPA JOSEPH C CEO

  • Officer
  • Director
  • CHAIRMAN
118,515 2016-02-26 0

BOOTHE DOUGLAS EVP & GM PERRIGO PHARMA

  • Officer
803 2016-02-26 0

COUCKE MARC EXECUTIVE VP & GM

  • Officer
5,397,711 2016-02-26 0

GOTTFRIED RAN

  • Director
12,728 2015-11-19 0

GIBBONS DAVID T

  • Director
14,191 2015-11-04 0

YU LOUIS EXECUTIVE VP GLOBAL QUALITY

  • Officer
10,898 2015-08-21 0

STEWART MICHAEL ROBERT SR. VP GLOBAL HUMAN RESOURCES

  • Officer
4,292 2015-08-21 0

SHAH JATIN SR VP & CHIEF SCIENTIFIC OFFIC

  • Officer
4,426 2015-08-21 0

JAMISON SCOTT F

  • EXECUTIVE VICE PRESIDENT PBM
5,196 2015-08-21 0

ZILBERFARB BEN-ZION

  • Director
0 2013-12-18 0

LEBEL REFAEL EVP & GM PERRIGO ISRAEL

  • Officer
6,218 2011-12-01 0

ARKIN MOSHE

  • Director
4,984,397 2011-08-31 0

MANNING PAUL B EVP & GENERAL MANAGER, PBM

  • Officer
0 2010-06-09 0

TOMSHACK JAMES SENIOR VP OF CHC SALES

  • Officer
8,914 2009-08-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PERRIGO CO PLC PRGO 2021-10-26 22:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 21:45:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 21:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 20:45:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 20:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 19:45:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 19:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 18:45:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 18:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 17:45:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 17:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 16:45:04 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 16:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 15:45:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 15:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 14:45:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 14:15:05 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 13:45:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 13:15:03 UTC -0.18 0.25 5500000
PERRIGO CO PLC PRGO 2021-10-26 12:45:03 UTC -0.18 0.25 5500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Absolute 500 Core Fund PRGO -34.0 shares, $-1635.06 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund PRGO -277.0 shares, $-13320.93 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund PRGO -199.0 shares, $-11122.11 2019-09-30 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund PRGO -2137.0 shares, $-95566.64 2020-12-31 N-PORT
FundVantage Trust- Gotham Neutral 500 Fund PRGO -375.0 shares, $-15176.25 2021-03-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF PRGO -5830.0 shares, $-267305.5 2021-06-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund PRGO -424.0 shares, $-19440.4 2021-06-30 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund PRGO -34.0 shares, $-1558.9 2021-06-30 N-PORT
FundVantage Trust- Gotham Hedged Core Fund PRGO -685.0 shares, $-31407.25 2021-06-30 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund PRGO -1554.0 shares, $-71250.9 2021-06-30 N-PORT
Federated Hermes Equity Funds- Federated Hermes Prudent Bear Fund PRGO -4000.0 shares, $-183400.0 2021-06-30 N-PORT

Elevate your investments